Evidence map›Paper›PMID 23486834›Full record

ArticleStem cells translational medicine2013

Recellularization of acellular human small intestine using bone marrow stem cells.

Pradeep B Patil, Priti B Chougule, Vijay K Kumar, Stefan Almström, Henrik Bäckdahl, Debashish Banerjee, Gustaf Herlenius, Michael Olausson, Suchitra Sumitran-Holgersson

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Stem cells translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Next-Generation Therapies for Gastrointestinal Repair: Converging Traditional Medicine and Tissue Engineering.JGH open : an open access journal of gastroenterology and hepatology · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Advances and Current Challenges in IntestinalFrontiers in bioengineering and biotechnology · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Extracellular Matrix Bioscaffolds for Building Gastrointestinal Tissue.Cellular and molecular gastroenterology and hepatology · 2018
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Decellularized scaffolds as a platform for bioengineered organs.Current opinion in organ transplantation · 2014
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Pradeep B PatilLaboratory for Transplantation and Regenerative Medicine, Department of Surgery, University of Gothenburg, Sweden.
Priti B Chougule
Vijay K Kumar
Stefan Almström
Henrik Bäckdahl
Debashish Banerjee
Gustaf Herlenius
Michael Olausson
Suchitra Sumitran-Holgersson
University of Gothenburg · SESahlgrenska University Hospital · SEUniversity of Borås · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to produce an acellular human tissue scaffold with a view to test the possibility of recellularization with bone marrow stem cells to produce a tissue-engineered small intestine (TESI). Human small-bowel specimens (n = 5) were obtained from cadaveric organ donors and treated sequentially with 6% dimethyl sulfoxide in hypotonic buffer, 1% Triton X-100, and DNase. Each small intestine (SI) piece (6 cm) was recellularized with EPCAM+ and CD133+ allogeneic bone marrow stem cells. Histological and molecular analysis demonstrated that after decellularization, all cellular components and nuclear material were removed. Our analysis also showed that the decellularized human SI tissue retained its histoarchitecture with intact villi and major structural proteins. Protein films of common extracellular matrix constituents (collagen I, laminin, and fibronectin) were found in abundance. Furthermore, several residual angiogenic factors were found in the decellularized SI. Following recellularization, we found viable mucin-positive goblet cells, CK18+ epithelial cells in villi adjacent to a muscularis mucosa with α-actin+ smooth muscle cells, and a high repopulation of blood vessels with CD31+ endothelial cells. Our results show that in the future, such a TESI would be ideal for clinical purposes, because it can be derived from the recipient's own immunocompatible bone marrow cells, thus avoiding the use of immunosuppression.

Indexed as

AC133 AntigenAntigens, CDAntigens, NeoplasmBiomechanical PhenomenaBone Marrow CellsCell Adhesion MoleculesCell CountCell ShapeEndothelial CellsEpithelial Cell Adhesion MoleculeFluorescent Antibody TechniqueGlycoproteinsHumansIntercellular Signaling Peptides and ProteinsIntestine, SmallMyocytes, Smooth MuscleAC133 AntigenAntigens, CDAntigens, NeoplasmCell Adhesion MoleculesEpithelial Cell Adhesion MoleculeGlycoproteinsIntercellular Signaling Peptides and ProteinsPeptidesPROM1 protein, human

Identifiers

PMID23486834
PMCPMC3659833
OpenAlexW2085436941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.